Abstract
Pain is one of the major symptoms of bone cancer. In 1984, 19 million cancer patients around the world suffered pain (Elliot and Foley, 1989). The prevalence of cancer pain is an important problem, as 30% of patients receiving curative treatment and 70% of patients with palliative care suffer pain because of the progression of the tumour (Greenwald et al, 1987).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beecher HK (1956) Relationship of significance of wound to pain experienced. JAMA 161: 1609–1613.
Berenson JR, Lichenstein A, Porter L et al (1996) Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 334: 488–493.
Bonica JJ, Loeser JD (1990) Medical evaluation of the patient with pain. In: Bonica JJ, Loeser JD, Chapman CR et al (eds) The management of pain, 2nd edn. Lea Febiger, Pennsylvania, pp 563–580.
Clain A (1965) Secondary malignant disease of bone. Br J Cancer 19: 5.
De Conno F, Caraceni A (1996) Manual of cancer pain. pp 19.
De Conno F, Ripamonti C, Sbanotto A et al (1993) A clinical note on sublingual buprenorphine. J Palliative Care 9: 44–46.
Durandeau A, Genste R (1989) Traitement chirurgical des fractures métastatiques et des métastases des os longs. A propos de 73 cas. Revue de Chirurgie Orthopédique et Réparatrice de l’Appareil Locomoteur 75: 1–10.
Elliot K, Foley KM (1989) Neurologic pain syndromes in patients with cancer. Neurol Clin 7: 333–360.
Erickson MH (1959) Hypnosis in painful terminal illness. Am J Clin Hypn 1: 117–121.
Fidler M (1981) Incidence of fractures through metastases in long bones. Acta Orthop Scand 52: 623–627.
Fine PG, Marcus M, DeBoer AJ et al (1991) An open label study of oral transmucosal fentanyl citrate ( OTFC) for the treatment of breakthrough cancer pain. Pain 45: 149–155.
Greenwald HP, Bonica JJ, Bergner M (1987) The prevalence of pain in four cancers. Cancer 60: 2563–2569.
Holland JC (1993) Principles of psychooncology. In: Holland JC, Frei E (eds) Cancer medicine, 3rd edn. Lea & Febiger, Philadelphia, pp 1017–1033.
Holroyd J (1996) Hypnosis treatment of clinical pain: understanding why hypnosis is useful. Int J Clin Exp Hypn XLIV(1): 33–51.
Korte W, De Stoutz N, Morant R (1996) Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short-and long-term experiences in a prospective study of 39 patients. J Pain Symptom Management 11: 139–146.
Krakowski I (1996) Chirurgie, radiotherapie et traitements médicaux spécifiques dans la prise en charge de la douleur cancéreuse. In: European School of Oncology (eds) Douleur et cancer, pp 51–68.
Krakowski I, Falcoff H, Gestin Y et al (1995) Recommandations pour une bonne pratique dans la prise en charge de la douleur du cancer chez l’adulte et l’enfant. Opération «Standards, Options et Recommandations» en cancérologie de la Fédération Nationale des Centres de Lutte Contre Le Cancer. Bulletin du Cancer 82 (suppl 4): 244–315.
Miser AW, Narang PK, Dothge JA et al (1989) Transdermal fentanyl for pain control in patients with cancer. Pain 37: 15–21.
Sacerdote P (1980) Hypnosis and terminal illness. In: Burroughs GD, Dennerstein L (eds) Handbook of hypnosis and psychosomatic medicine. Elsevier/North-Holland Biomedical Press, New York.
Spiegel D (1981) Hypnosis in the treatment of psychosomatic symptoms and pain. Psychiatric Ann 11 (9): 24–30.
Spiegel D, Bloom JR (1983a) Pain in metastatic breast cancer. Cancer 52: 341–345.
Spiegel D, Bloom JR (1983b) Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 45: 333–339.
Trijsburg RW, Van Knippenberg FCE, Rijpma SE (1992) Effects of psychological treatment on cancer patients: a critical review. Psychosom Med 54: 489–517.
Tubiana-Hulin M (1996) Traitements médicaux des métastases osseuses. Bulletin du Cancer/ Radiothérapie 83: 299–304.
Turner JH, Claringbold PG, Hetherington EL (1989) A phase I study of samarium-153 ethylnediaminetetramethylene phosphonate therapy for disseminated skeletal metastases. J Clin Oncol 7: 1926–1931.
Woodforde JM, Fielding JR (1970) Pain and cancer. J Psychosom Res 14: 365–370.
World Health Organization (1996) Cancer pain relief, 2nd edn. World Health Organization, Geneva.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag London
About this chapter
Cite this chapter
Baciuchka-Palmaro, M., Mouysset, J.L., Spiegel, D. (2002). Therapeutic Approaches to Bone Cancer Pain. In: Poitout, D.G. (eds) Bone Metastases. Springer, London. https://doi.org/10.1007/978-1-4471-3251-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3251-6_14
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3253-0
Online ISBN: 978-1-4471-3251-6
eBook Packages: Springer Book Archive